[1. Liu YC, Lin MT, Wang JK, Wu MH. State of the art acute phase management of Kawasaki disease after 2017 scientific statement from American Heart Association. Pediatrics and Neonatology. 2018;59;543-552.10.1016/j.pedneo.2018.03.00529706362]Search in Google Scholar
[2. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation. 2017;135:e927-999.]Search in Google Scholar
[3. Iordachescu F. Tratat de Pediatrie. Editura ALL; 2019.]Search in Google Scholar
[4. Saguil A, Fargo M, Grogan S. Diagnosis and management of Kawasaki disease. American family physician. 2015 Mar 15 [PubMed PMID: 25822554].]Search in Google Scholar
[5. Lang B, Recognizing Kawasaki disease. Paediatrics [PubMed PMID: 20084135].]Search in Google Scholar
[6. Huang YH, Kuo HC. Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker. Int J Mol Sci. 2017;18(4):820;https://doi.org/10.3390/ijms18040820.10.3390/ijms18040820541240428417923]Search in Google Scholar
[7. Denby KJ, Clark DE, Markham LW. Management of Kawasaki disease in adults. Heart (British Cardiac Society). 2017 Nov [PubMed PMID: 28751537].10.1136/heartjnl-2017-31177428751537]Search in Google Scholar
[8. Tsuda E, Singhal M, Role of imaging studies in Kawasaki disease. International journal of rheumatic diseases. 2018 Jan [PubMed PMID: 29115035].]Search in Google Scholar